1Glueck CJ, Phyllips H, Cameron D, et al. The 4G/4G polymorphism of the hypo-fibrinolytic plasminogen activator inhibitor type 1 gene: an independent risk factor for serious pregnancy complications. Metab Clin Exp, 2000,49: 845-852.
2Ogunyemi D, Ku W, Arkel Y. The association between inherited thrombophilia, antiphospholipid antibodies and lipoprotein A levels with obstetrical complications in pregnancy. J Thromb Thrombolysis, 2002,14 : 157-162.
7Brenner B. Inherited thrombophilia and fetal loss. Curr Opin Hematol, 2000,7: 290-295.
8Haverkate F, Samama M. Familial dysfibrinogenemia and thrombophilia. Report on a study of the SSC Subcommittee on Fibrinogen. Thromb Haemost, 1995,73 : 151-161.
9Sarig G,Younis JS, Hoffman R, et al. Thrombophilia is common in women with idiopathic pregnancy loss and is associated with late pregnancy wastage. Fertil Steril,2002,77: 342-347.
10Kupferminc MJ, Eldor A, Steinman N, et al. Increased frequency of genetic thrombophilia in women with complications of pregnancy. N Engl J Med,1999,340:9-13.
二级参考文献14
1郑怀美.妇产科学（第3版）[M].北京:人民卫生出版社,1991.113-114.
2McDonald L et al. The Lancet . 1957
3Phear D et al. The Lancet . 1957
4Chung DW et al.Fibrinogen, Thrombosis, coagulation, and Fibrinolysis[]..1990
5Baumann H et al. Immunology Today . 1994
6Montgomery HE et al. Arteriosclerosis and Thrombosis . 1996
7Roy SN et al. Journal of Biological Chemistry . 1990
8Mizuguchi J et al. Journal of Biological Chemistry . 1995
9Hu CH et al. Journal of Biological Chemistry . 1995
10Dalmon J et al. Molecular and Cellular Biology . 1993
